People · Operator
Named in public records as an officer, director or promoter · active 2016–2016 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cellerant Therapeutics Inc | — | Biotechnology | Series A | $18.2M | $236.8M | 2016 |
Robby Hogle at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robby Hogle on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Lowell Sears | 1 | 3 |
| Richard G. Rathmann | 1 | 2 |
| Gisela Schwab | 1 | 2 |
| Stephen Greenberg | 1 | 2 |
| Richard G. Chyette | 1 | 1 |
| Gisela G. Schwab | 1 | 1 |
| Lowell G. Sears | 1 | 1 |
| Rodney Young | 1 | 1 |
| Richard Chyette | 1 | 1 |
| Ramkumar Mandalam | 1 | 1 |
| Antoun G. Nabhan | 1 | 1 |
| Stephen G. Greenberg | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.